Lean body mass
Increase · moderate
Androgen receptor activation in muscle
Literature evidence
Compound library
Vivy evidence dossier
Ostarine
T2General Wellness
Read this entry as context, not instruction.
Evidence labels describe the material available in this reference entry. They do not establish that a compound is appropriate, effective, or safe for you. Inclusion is not a recommendation to use it.
Observed relationships
Biomarker context
Total testosterone
Decrease · moderate
HPT axis suppression
Literature evidence
LH
Decrease · moderate
Pituitary feedback suppression
Literature evidence
FSH
Decrease · moderate
Pituitary feedback suppression
Literature evidence
SHBG
Decrease · small
Androgen feedback
Literature evidence
HDL cholesterol
Decrease · moderate
Androgenic lipid effects
Literature evidence
LDL cholesterol
Increase · small
Androgenic lipid effects
Literature evidence
ALT
Increase · small
Hepatic strain
Literature evidence
Hematocrit
Increase · small
Androgenic erythropoiesis
Literature evidence
Blood pressure
Increase · small
Androgenic vascular effects
Literature evidence
ApoB
Increase · small
Androgenic lipid effects
Literature evidence
LDL-P
Increase · small
Increases atherogenic particles
Literature evidence
Triglycerides
Increase · small
Androgenic lipid effects
Literature evidence
PSA
Increase · small
Androgen receptor activation
Literature evidence
Keep the reference close
Track Ostarine in context.
Hey Vivy helps you organize protocols and review change over time. It does not diagnose, prescribe, or replace qualified care.